Food and Drug Administration updated its label requirements for the drug labels on fluoroquinolone-based medications.

After NuVision Pharmacy refused FDA’s most recent request to recall all of its sterile products, FDA is reminding health care providers not to use NuVision sterile products.

Specialty Compounding, LLC, clarified a recall of all lots of sterile compounded medications produced in its Texas facility.

The American Society of Health-System Pharmacists (ASHP) and the Accreditation Council for Pharmacy Education (ACPE) have announced the creation of the Pharmacy Technician Accreditation Commission.

The Consumer Healthcare Products Association (CHPA) has filed a citizen petition to FDA that asks the agency to provide convenient and accurate access to dosing information for children ages six months to two years.

Following a controversial conditional veto by Governor Chris Christie, New Jersey has become one of several states that allow children with issues like seizures, autism, and cancer, legal access to an edible form of medical marijuana.

Many licensed professionals are subject to codes of ethics and other standards of practice that limit and, in some cases, prohibit personal relationships with patients/clients.

The risks of ordering medications online and of receiving dangerous counterfeit products are highlighted in a recent NBC Connecticut report.

US Department of Justice (DOJ) officials indicted 11 people on 17 different charges related to the illegal importation and distribution of non-Food and Drug Administration (FDA)-approved drugs into the US.

The state of Georgia became the second-to-last state to implement a prescription monitoring program.

United Parcel Service (UPS) has become the first global package delivery organization to join the Center for Safe Internet Pharmacies (CSIP) as a strategic partner and board member.

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDAC) in Boston, MA.

Food and Drug Administration (FDA) has announced a voluntary recall of all lots of unexpired sterile products produced by Specialty Compounding, LLC, in Cedar Park, TX.

In a July 2013 report, the United States Government Accountability Office (GAO) recommends that “Congress should consider clarifying FDA’s authority to oversee certain entities that compound drugs.”

FDA has issued a Consumer Update that warns of rare but serious skin reactions that may occur in patients taking acetaminophen.

Alabama Governor Robert Bentley has signed into law three bills aimed to reverse the state’s growing prescription drug abuse rate. 

Centers for Medicare and Medicaid Services (CMS) has become aware of cases in which veterinarians are told, incorrectly, that they must provide a National Provider Identifier (NPI) number for prescriptions they have written to be dispensed.

In a study recently published by the Journal of Pediatrics, researchers concluded that flow regulators for liquid medication bottles are an effective way to limit the amount of medication administered to young children. 

The Tennessee Controlled Substance Monitoring Database Program has now deployed the NABP PMP InterConnect®.

On August 1, 2013, Illinois Governor Pat Quinn signed into law the Compassionate Use of Medical Cannabis Pilot Program Act, making Illinois the 21st state to legalize some form of medical marijuana. 

Nova Diabetes Care and Food and Drug Administration (FDA) officials have announced a voluntary recall of 21 lots of blood glucose test strips.

According to a state report released in late July, drug overdose deaths in the state of Kentucky decreased by 19 to 1,004.